Negócios · 25/03/20111 min de leitura
The National Antimicrobial Resistance Monitoring System Strategic Plan 2011-2015; Request for Comments; Extension of Comment Period
Tradução automática local · Idioma original da fonte
Resumo
The Food and Drug Administration (FDA) is extending the comment period for the notice that appeared in the Federal Register of January 24, 2011 (76 FR 4120). In the notice, FDA requested comments on a document for the National Antimicrobial Resistance Monitoring System (NARMS) entitled "NARMS Strategic Plan 2011-2015." The Agency is taking this action in response to requests for an extension to allow interested persons additional time to submit comments. Based on requests received, additional information is being placed in the docket related to the development of the Strategic Plan. This information can also be viewed at the Web sites listed in section III of this document.